Overview


Alanine Aminotransferase (ALT) reagent is one of the enzymes within the aminotransferases group and is among the most sensitive liver enzymes. The highest concentrations of the alanine aminotransferase enzyme can be in the liver, with low concentrations found in the kidneys, heart, pancreas, skeletal muscle, spleen, and lung tissue. Alanine aminotransferase measurements diagnose hepatic damage and diseases, including viral hepatitis and cirrhosis. The concentration levels of alanine aminotransferase in the blood are low. However, when injured, the liver releases more ALT into the blood, increasing the concentration levels. When diagnosing hepatic damage, the root cause of the damage can be determined, such as disease, drug, or injury. The ALT test allows for the diagnosis of liver disease as well as the diagnosis of the cause of the disease. 

Spectrophotometric detection is the widely adopted clinical standard method in determining the serum concentration of alanine transferase. In this detection method, the absorbance change of NADH concentration at 340 nm UV light is measured based on the pyruvate reaction with lactate dehydrogenase. However, spectrophotometric methods require physically large and expensive instruments, skillful technicians, and relatively large sample volumes around a few milliliters. Thus, the spectrophotometric analysis is not suitable for point-of-care or home-use detection of ALT. Ideally, ALT detection can be accomplished with a relatively small-scale, portable, inexpensive, and disposable sensor that utilizes a simple detection method.

FutureWise Market Research has published a report that provides an insightful analysis alanine aminotransferase reagent market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, alanine aminotransferase reagent market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  •  Abbott Laboratories
  •  Randox Laboratories Ltd.
  •  Roche Diagnostics
  •  Siemens Medical System
  •  SKFDIA Beckman Coulter Inc
  •  J J Clinical Diagnostic
  •  Medtest DX
  •  Thermo Scientific, Diatron
  •  Horiba Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of liver diseases and hepatic disorders is a significant driver for the growing demand for liver function tests, such as alanine aminotransferase, expected to propel the market in the forecast period. Liver conditions, including viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), and cirrhosis, are becoming more common globally due to unhealthy lifestyle choices, obesity, alcohol consumption, and viral infections. As these conditions often progress silently, early detection and monitoring of liver function are crucial for timely intervention and effective management. ALT testing plays a key role in diagnosing and assessing liver health, as elevated ALT levels indicate liver cell damage or injury. Moreover, the growing demand for point-of-care testing and home-based diagnostics offers a favorable opportunity for alanine aminotransferase reagent manufacturers to penetrate emerging markets and serve evolving consumer preferences. As healthcare systems focus on diagnostic services and improving accessibility, point-of-care testing offers the advantage of delivering rapid results directly at the patient's place, eliminating the need for central laboratories and reducing turnaround times. ALT reagent manufacturers may exploit this by developing user-friendly and reliable rapid test kits that are easy to use for healthcare professionals in decentralized settings and patients in the comfort of their homes. Furthermore, limited access to healthcare facilities and diagnostic centers, especially in developing regions, poses a significant restraint to the growth of the alanine aminotransferase market during the forecast period. In these developing regions, inadequate infrastructure, shortage of skilled healthcare professionals, and financial conditions may hinder the timely diagnosis and monitoring of liver diseases.

By Product Type

  •  Assay buffer
  •  Substrate mix
  •  Cofactor
  •  Enzyme

By Application

  •  Test kits
  •  Standalone testing

By Distribution Channel

  •  Hospitals
  •  Pathology centers
  •  Kit manufacturers
  •  POC testing

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the rising incidence of liver injuries and hepatic disorders, there has been a significant increase in the demand for the alanine aminotransferase (ALT) test in the region. With higher prevalence rates of liver diseases, the demand for diagnostic tests such as the alanine aminotransferase (ALT) test has surged. For instance, in North America, where non-alcoholic fatty liver disease and alcoholic liver disease are on the rise, there has been a significant rise in the adoption of alanine aminotransferase tests to assess liver health.

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the Alanine Aminotransferase Reagent Market By Product Type, By Application, By Distribution Channel and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Alanine Aminotransferase Reagent Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alanine Aminotransferase Reagent Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Alanine Aminotransferase Reagent Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Alanine Aminotransferase Reagent Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Assay buffer
        2. Substrate mix
        3. Cofactor
        4. Enzyme

  • 8.   Global Alanine Aminotransferase Reagent Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Test kits
        2. Standalone testing

  • 9.   Global Alanine Aminotransferase Reagent Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Pathology centers
        3. Kit manufacturers
        4. POC testing

  • 10.   North America Alanine Aminotransferase Reagent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Alanine Aminotransferase Reagent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Alanine Aminotransferase Reagent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Alanine Aminotransferase Reagent Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Randox Laboratories Ltd.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Roche Diagnostics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Siemens Medical System
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. SKFDIA Beckman Coulter Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. J J Clinical Diagnostic
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtest DX
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Thermo Scientific, Diatron
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Horiba Medical
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients